Machida T, Kubota M, Kobayashi E, et?al. anti\SOHLH antibodies (Abs) in the sera of sufferers with colorectal cancers (CRC) had been markedly higher. Furthermore, no relationship was observed between five SEREX antigens as well as the three tumor markers (CEA, CA19\9, and anti\p53 Abs), indicating that anti\FIRexon2 Abs are an unbiased applicant marker for sufferers […]